Rezolute, Inc. reported earnings results for the first quarter ended September 30, 2022. For the first quarter, the company reported net loss was USD 9.83 million compared to USD 7.84 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.31 USD | +11.45% | +24.44% | +233.50% |
18/04 | JonesTrading Starts Rezolute With Buy Rating, $10 Price Target | MT |
06/03 | Rezolute, Inc. Reports Validation of the Potential Use of RZ358 for Treatment of Non-Islet Cell Tumor Hypoglycemia | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+233.50% | 119M | |
-1.43% | 103B | |
+8.96% | 101B | |
+4.40% | 23.07B | |
-12.15% | 22.23B | |
-4.36% | 18.05B | |
-39.98% | 17.18B | |
-10.04% | 16.94B | |
+6.79% | 14.07B | |
+38.61% | 12.35B |
- Stock Market
- Equities
- RZLT Stock
- News Rezolute, Inc.
- Rezolute, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2022